340B Drug Pricing: Access vs. Profit

Substantial reform is on the horizon for a little-known program that is meant to help expand patient access to healthcare with savings from discounted drug prices. We take directly from legislative debate over how Illinois can regulate the federal 340B drug pricing program, which stalled in the House after passing the Senate unanimously in the final days of the spring session, but is likely to return this fall. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit ilcapitolgroup.substack.com